| Laria Eye Care | |
|
8220 W Flagler St, Miami, FL 33144-2028 | |
| (305) 225-1145 | |
| Not Available |
| Full Name | Laria Eye Care |
|---|---|
| Type | Facility |
| Speciality | Technician/technologist - Optician |
| Location | 8220 W Flagler St, Miami, Florida |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053480145 | NPI | - | NPPES |
| 620974200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC3913 (Florida) | Secondary |
| 156FX1800X | Technician/technologist - Optician | (* (Not Available)) | Primary |
| Provider Name | Lianette Laria |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437105962 PECOS PAC ID: 3971553991 Enrollment ID: I20050128000450 |
News Archive
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
Scientists found a deadly parasite with some of its chromosomes in duplicate, others in triplicate, while still others are present four or even five times. Moreover, the copy number varies between individuals. Such a bizarre occurrence has never before been found in nature, in any organism. As a rule, chromosomes should come in couples. The scientists, from the Institute of Tropical Medicine (ITG) and the Wellcome Trust Sanger Institute, made the striking discovery while deciphering the genetic code of a series of Leishmania-parasites.
One major problem in treating cancer is identifying the location of small tumors and treating them before they metastasize.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
› Verified 6 days ago
| Provider Name | Diana Perez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295263903 PECOS PAC ID: 7911241518 Enrollment ID: I20181210000831 |
News Archive
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
Scientists found a deadly parasite with some of its chromosomes in duplicate, others in triplicate, while still others are present four or even five times. Moreover, the copy number varies between individuals. Such a bizarre occurrence has never before been found in nature, in any organism. As a rule, chromosomes should come in couples. The scientists, from the Institute of Tropical Medicine (ITG) and the Wellcome Trust Sanger Institute, made the striking discovery while deciphering the genetic code of a series of Leishmania-parasites.
One major problem in treating cancer is identifying the location of small tumors and treating them before they metastasize.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
› Verified 6 days ago
| Provider Name | Aurora Perez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1811160187 PECOS PAC ID: 5698013506 Enrollment ID: I20190218002720 |
News Archive
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
Scientists found a deadly parasite with some of its chromosomes in duplicate, others in triplicate, while still others are present four or even five times. Moreover, the copy number varies between individuals. Such a bizarre occurrence has never before been found in nature, in any organism. As a rule, chromosomes should come in couples. The scientists, from the Institute of Tropical Medicine (ITG) and the Wellcome Trust Sanger Institute, made the striking discovery while deciphering the genetic code of a series of Leishmania-parasites.
One major problem in treating cancer is identifying the location of small tumors and treating them before they metastasize.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laria Eye Care 8220 W Flagler St, Miami, FL 33144-2028 Ph: (305) 225-1145 | Laria Eye Care 8220 W Flagler St, Miami, FL 33144-2028 Ph: (305) 225-1145 |
News Archive
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
Scientists found a deadly parasite with some of its chromosomes in duplicate, others in triplicate, while still others are present four or even five times. Moreover, the copy number varies between individuals. Such a bizarre occurrence has never before been found in nature, in any organism. As a rule, chromosomes should come in couples. The scientists, from the Institute of Tropical Medicine (ITG) and the Wellcome Trust Sanger Institute, made the striking discovery while deciphering the genetic code of a series of Leishmania-parasites.
One major problem in treating cancer is identifying the location of small tumors and treating them before they metastasize.
Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.
› Verified 6 days ago